These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28056198)

  • 1. Reply to R.F. Sweis et al.
    Schmid P; Pinder SE; Purushotham A; Thompson AM
    J Clin Oncol; 2017 Jan; 35(2):261-262. PubMed ID: 28056198
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Runqiang Yuan's Letter to the Editor re: James T. Kearns, Anna V. Faino, Lisa F. Newcomb, et al. Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study. Eur Urol 2018;73:706-12.
    Kearns JT; Newcomb LF; Lin DW
    Eur Urol; 2018 Dec; 74(6):e151. PubMed ID: 30195835
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to R.D. Nipp et al, M.-J. Molina-Garrido et al, and A. Gajra et al.
    Corre R; Léna H; Vergnenègre A; Chouaïd C
    J Clin Oncol; 2016 Nov; 34(33):4050-4051. PubMed ID: 27551125
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to K. Quan et Al, S.P. Collins et al, C.R. King et al, s. Arcangeli et al, d.B. Fuller, and D. Vordermark.
    D'Amico AV
    J Clin Oncol; 2014 Oct; 32(30):3457. PubMed ID: 25185103
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Stephen B. Williams and John F. Ward's Letter to the Editor re: Jan P. Radtke, Constantin Schwab, Maya B. Wolf, et al. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.12.052.
    Hadaschik BA; Radtke JP
    Eur Urol; 2016 Sep; 70(3):e79-80. PubMed ID: 26995329
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to F. Tomao et al.
    Ribi K; Bernhard J; Luo W; Regan MM; Fleming GF; Francis PA
    J Clin Oncol; 2016 Dec; 34(34):4189-4190. PubMed ID: 27621403
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to M.J. Brenner et al and I.R. Vogelius et al.
    Pollack A; Walker G; Horwitz EM; Price R; Feigenberg S; Konski AA; Stoyanova R; Movsas B; Greenberg RE; Uzzo RG; Ma C; Buyyounouski MK
    J Clin Oncol; 2014 Jun; 32(17):1853-4. PubMed ID: 24778402
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to R.L. Nussbaum et al and J.S. Dolinsky et al.
    Balmaña J; Nathanson K; Offit K; Robson M; Domchek S
    J Clin Oncol; 2017 Apr; 35(11):1262-1263. PubMed ID: 28135137
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to R. Colomer et al.
    Durkee BY; Qian Y; Goldhaber-Fiebert JD; Horst KC
    J Clin Oncol; 2016 Sep; 34(26):3227-8. PubMed ID: 27432936
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to Glen Denmer Santok and Koon Ho Rha's Letter to the Editor re: Pär Stattin, Fredrik Sandin, Frederik Birkebæk Thomsen, et al. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.023.
    Stattin P; Bratt O
    Eur Urol; 2017 Apr; 71(4):e115-e116. PubMed ID: 27720538
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to R. Fonseca et al.
    Khorana AA; Janas M; Jarner MF; Lee AYY
    J Clin Oncol; 2017 Jul; 35(19):2218-2219. PubMed ID: 28481706
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to F. Valcamonico et al.
    Smith MR; Halabi S; Small EJ
    J Clin Oncol; 2014 Nov; 32(32):3685. PubMed ID: 25225438
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Yuri Tolkach, Markus Kuczyk, Florian Imkamp's letter to the editor re: Eric A. Klein, Matthew R. Cooperberg, Cristina Magi-Galluzzi, et al. A 17-gene assay to predict prostate cancer aggressiveness in the context of gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur urol 2014;66:550-60.
    Klein EA; Cooperberg MR; Carroll PR
    Eur Urol; 2014 Dec; 66(6):e117-8. PubMed ID: 25150174
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to Yaalini Shanmugabavan, Stephanie Guillaumier and Hashim U. Ahmed's letter to the editor re: Morgan R. Pokorny, Maarten de Rooij, Earl Duncan, et al. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol 2014;66:22-9.
    Pokorny M; Van de Ven W; Barentsz J; Thompson L
    Eur Urol; 2015 Mar; 67(3):e54-5. PubMed ID: 25194908
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to O. Corli et al and M. Lucchesi et al.
    Kaasa S
    J Clin Oncol; 2016 Oct; 34(29):3581-3582. PubMed ID: 27458292
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to O. Corli et al and M. Lucchesi et al.
    Bandieri E; Romero M; Ripamonti CI; Artioli F; Fanizza C; Cascinu S; Bruera E; Luppi M
    J Clin Oncol; 2016 Oct; 34(29):3580-3581. PubMed ID: 27458301
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to F Teymoori et al.
    Dibaba DT; Xun P; He K
    Am J Clin Nutr; 2018 Feb; 107(2):293. PubMed ID: 29529151
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to I. R. Vogelius et al.
    Kerkmeijer LGW; Pos FJ; Haustermans K; van der Heide UA
    J Clin Oncol; 2021 Sep; 39(27):3086-3087. PubMed ID: 34086505
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: James T. Kearns, Anna V. Faino, Lisa F. Newcomb, et al. Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study. Eur Urol 2018;73:706-12.
    Yuan R
    Eur Urol; 2018 Dec; 74(6):e149-e150. PubMed ID: 30177284
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to Yi Zhou, Weigang Yan, and Hanzhong Li's Letter to the Editor re: Eduard Baco, Erik Rud, Lars Magne Eri, et al. A Randomized Controlled Trial to Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy. Eur Urol 2016;69:149-56.
    Baco E; Rud E; Vlatkovic L
    Eur Urol; 2016 Aug; 70(2):e55. PubMed ID: 26852076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.